Monograph Details
|
|
Eye Disorders
> Glaucoma
|
|
TRAVATAN |
| Manufacturer |
|
Alcon Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Prostaglandin analogue. |
| Generic Name |
|
Travoprost 0.004%; oph soln; contains benzalkonium chloride. |
| Also |
|
• TRAVATAN Z
|
| Indications |
|
Open-angle glaucoma or ocular hypertension in patients who are intolerant of, or who have had an insufficient response to, other agents. |
| Children |
|
Not recommended. |
| Adults |
|
1 drop once daily in the PM. |
| Precautions |
|
Do not exceed recommended dose. Active intraocular inflammation: not recommended; caution with history thereof. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Benzalkonium chloride may be absorbed by contact lenses (remove; may reinsert lenses 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Allow at least 5 minutes between application of other topical ophthalmic agents. |
| Adverse Reactions |
|
Ocular hyperemia, decreased visual acuity; eye discomfort, pain or itching; foreign body sensation, other local reactions, increased ocular pigmentation (iris, eyelid, eyelashes; may be permanent), other eyelash changes, photophobia, blepharitis, cataract, keratitis, rash, angina, bradycardia, headache. |
| How Supplied |
|
Soln—2.5mL, 5mL |
|
|
|
|
